Vaccination with soluble Aβ oligomers generates toxicity‐neutralizing antibodies
Open Access
- 1 November 2001
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 79 (3), 595-605
- https://doi.org/10.1046/j.1471-4159.2001.00592.x
Abstract
In recent studies of transgenic models of Alzheimer's disease (AD), it has been reported that antibodies to aged beta amyloid peptide 1–42 (Aβ1−42) solutions (mixtures of Aβ monomers, oligomers and a...Keywords
This publication has 42 references indexed in Scilit:
- Reversible Inactivation of Superoxide‐Sensitive Aconitase in Aβ1‐42‐Treated Neuronal Cell LinesJournal of Neurochemistry, 2000
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- Cytotoxic Amyloid Peptides Inhibit Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction by Enhancing MTT Formazan ExocytosisJournal of Neurochemistry, 1997
- Amyloid β-Protein FibrillogenesisJournal of Biological Chemistry, 1997
- Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's DiseaseJournal of Biological Chemistry, 1996
- Water-soluble Aβ(N-40, N-42) Oligomers in Normal and Alzheimer Disease BrainsJournal of Biological Chemistry, 1996
- Soluble multimeric Alzheimer β(1–40) pre-amyloid complexes in dilute solutionNeurobiology of Aging, 1995
- Radical AGEing in Alzheimer's diseaseTrends in Neurosciences, 1995
- β‐Cyclodextrin interacts with the Alzheimer amyloid β‐A4 peptideFEBS Letters, 1994
- Sequence and nethylation in the βA4 region of the rabbit anyloid precursor protein geneBiochemical and Biophysical Research Communications, 1992